Regulatory Webinars
-
Signant Health Clinical Leader Solutions Expo September 2025 - IRT
10/3/2025
Explore how organizations can transform from managing dozens of siloed, protocol-specific RTSM implementations to achieving unified, portfolio-level clinical operations.
-
Almac Clinical Leader Solutions Expo September 2025 - IRT
10/3/2025
Complexity is no longer the exception in high stakes clinical trials, it has become the rule.
-
IQVIA Technologies Clinical Leader Solutions Expo September 2025 - IRT
10/3/2025
Have you seen an increase in the number of IRT inspections over the past 3 years?
-
Patient Centered Research: Challenges And The Role Of HEOR
10/1/2025
This video features expert insights into the evolving landscape of Patient-Centered Research and the role of HEOR in risk-benefit assessments.
-
Navigating Disclosure Complexity: The Power Of Human-Centered AI
9/25/2025
Identify key regulatory hurdles that sponsors face when integrating Artificial Intelligence (AI), as well as the impact of AI on clinical trial disclosure and transparency.
-
Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views
9/23/2025
Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.
-
The New Era Of Project Optimus: Implications For Oncology Development Strategy
9/10/2025
In this presentation, expert speakers bring the impact of Project Optimus to life through real-world case studies and practical examples.
-
Best Practices For Operationalizing Global, Early-Phase Oncology Trials
9/10/2025
In this presentation, industry experts will share real-world lessons learned from managing global early-phase oncology trials.
-
Navigating What's Next For Global Drug Development: What Sponsors Need To Know
9/10/2025
Learn how new FDA initiatives and global regulatory changes can impact your strategy for 2025 and beyond.
-
Exploring Ex-US Markets To Reduce Risk For Your Clinical Trials
9/10/2025
How biotech and emerging pharma companies are increasingly leveraging regions such as APAC and Eastern Europe to accelerate trial start-up, secure high-quality data, and optimize costs.